Lowry Curley

Lowry is co-founder and CEO of AxoSim. He drives the vision and implementation for product development and commercialization of AxoSim’s NerveSim® and BrainSim® drug discovery platforms, with the goal of making a significant impact on medicine and patient care. Lowry received a Ph.D. in biomedical engineering from Tulane University focused on tissue engineering and neuroscience. He is active on HESI’s (Health and Environmental Science Institute) Neutox Committee, which is a national nonprofit that works to resolve global health and environmental challenges through the engagement of scientists from academia, government, industry, NGOs, and other strategic partners. Lowry is also an early member of the Nonclinical Innovation and Patient Safety Initiative collaboration (NIPSI) which advocates the FDA for use of safer, more effective non-animal testing models in drug discovery. Locally, he serves on the New Orleans BioDistrict Board, dedicated to supporting the economic growth of the biosciences sector in Southeast Louisiana.